Last reviewed · How we verify

NCT05925400: VR-INVENT

Interest of Virtual Reality in the Management of Anxiety and Pain During Embryo Transfer (ET)

Terminated NA Last updated 3 August 2025
What this trial tests

NA trial testing Virtual Reality during Embryo Transfer in IVF in 12 participants. Terminated before completion.

Timeline
15 November 2023
Primary endpoint
16 July 2025
16 July 2025

Quick facts

Lead sponsorCMC Ambroise Paré
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment12
Start date15 November 2023
Primary completion16 July 2025
Estimated completion16 July 2025
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

CMC Ambroise Paré — full company profile →

Who can join

Adults 18 to 43, female only, with IVF or Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study compares the use of virtual Reality versus the usual service protocol for the management of anxiety and pain related to In-Vitro fertilization (IVF) procedure

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for IVF

Currently open trials in the same condition.

Other CMC Ambroise Paré trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05925400.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing